EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma.
Tanaka K, Hida T, Oya Y, Oguri T, Yoshida T, Shimizu J, Horio Y, Hata A, Kaji R, Fujita S, Sekido Y, Kodaira T, Kokubo M, Katakami N, Yatabe Y.
Tanaka K, et al. Among authors: yoshida t.
J Thorac Oncol. 2015 Dec;10(12):1720-5. doi: 10.1097/JTO.0000000000000675.
J Thorac Oncol. 2015.
PMID: 26743855
Free article.